These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Management of insulinoma with the somatostatin analog SMS 201-995]. Gilsanz Peral A; Gómez Balaguer M; Costa Talens P Med Clin (Barc); 1988 Apr; 90(15):634-5. PubMed ID: 2899658 [No Abstract] [Full Text] [Related]
6. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995. Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592 [No Abstract] [Full Text] [Related]
7. Octreotide--a synthetic somatostatin. Med Lett Drugs Ther; 1989 Jul; 31(796):66-8. PubMed ID: 2567960 [No Abstract] [Full Text] [Related]
8. A case of somatostatinoma: responses to food and SMS 201-995 administration. Davis TM; Bray G; Domin J; Bloom SR Pancreas; 1988; 3(6):729-33. PubMed ID: 2906126 [TBL] [Abstract][Full Text] [Related]
9. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome. Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500 [TBL] [Abstract][Full Text] [Related]
10. The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors. Maton PN Gastroenterol Clin North Am; 1989 Dec; 18(4):897-922. PubMed ID: 2559036 [TBL] [Abstract][Full Text] [Related]
11. Octreotide: a somatostatin analog. Salman K; Rose LI Am Fam Physician; 1989 Jun; 39(6):207-11. PubMed ID: 2543196 [No Abstract] [Full Text] [Related]
12. Clinical review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors. Wynick D; Bloom SR J Clin Endocrinol Metab; 1991 Jul; 73(1):1-3. PubMed ID: 1646213 [TBL] [Abstract][Full Text] [Related]
13. Perioperative use of long-acting somatostatin analog (SMS 201-995) in patients with endocrine tumors of the gastroenteropancreatic axis. Tsai ST; Eckhauser FE; Thompson NW; Strodel WE; Vinik AI Surgery; 1986 Oct; 100(4):788-95. PubMed ID: 2876529 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin analogues in the management of benign insulinomas. Laron Z Isr J Med Sci; 1990 Jan; 26(1):1-2. PubMed ID: 2155883 [No Abstract] [Full Text] [Related]
15. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Maton PN; Gardner JD; Jensen RT Dig Dis Sci; 1989 Mar; 34(3 Suppl):28S-39S. PubMed ID: 2537716 [TBL] [Abstract][Full Text] [Related]
16. Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug? Stehouwer CD; Lems WF; Fischer HR; Hackeng WH Neth J Med; 1989 Aug; 35(1-2):86-94. PubMed ID: 2550827 [TBL] [Abstract][Full Text] [Related]
17. Clinical use of the somatostatin analog SMS 201-995 in endocrinology. Cozzi R; Liuzzi A; Dallabonzana D; Oppizzi G; Orlandi P; De Palo C; Petroncini MM; Piolini M; Chiodini PG J Endocrinol Invest; 1988 Nov; 11(10):737-40. PubMed ID: 2852695 [No Abstract] [Full Text] [Related]
18. [Clinical applications of octreotide in gastro-entero-pancreatic (GEP) tumors]. Arnold R; Neuhaus C; Trautmann M Z Gastroenterol; 1990 Sep; 28 Suppl 2():22-8. PubMed ID: 1980774 [No Abstract] [Full Text] [Related]
19. Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature. Rosenbaum A; Flourie B; Chagnon S; Blery M; Modigliani R Digestion; 1989; 42(2):116-20. PubMed ID: 2548911 [TBL] [Abstract][Full Text] [Related]
20. An important new treatment for carcinoid tumors and VIPomas. Oncology (Williston Park); 1988 Dec; 2(12):35-6. PubMed ID: 2856315 [No Abstract] [Full Text] [Related] [Next] [New Search]